

Author: Sennikov S.V. Krysov S.V. Silkov A.N. Injelevskaya T.V. Kozlov V.A.
Publisher: Academic Press
ISSN: 1043-4666
Source: Cytokine, Vol.17, Iss.4, 2002-02, pp. : 221-225
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
It has previously been determined that erythroid cells of mice are capable of expressing such cytokines as interleukin (IL) 1α and β, IL-4, IL-6, interferon gamma (IFN-γ), granulocyte–macrophage colony-stimulating factor (GM-CSF) and transforming growth factor beta (TGF-β). It has been shown that glycophorin A+ (GlA+) and antigen erythroblasts (AG-EB+) (both human erythroid cells of embryonic origin) are also capable of producing a series of cytokines such as IL-1β, IL-2, IL-4 and IL-6. The aim of this work was to study the capacity of erythroid cells from human embryonic liver to produce such cytokines as IFN-γ, TGF-β1, tumour necrosis factor alpha (TNF-α) and IL-10. The erythroid cells were isolated by means of antibodies specific to erythroblasts (GlA and AG-EB), as well as those from single erythroid colonies. The production level of some cytokines varies insignificantly under the action of erythropoietin (Epo) and quantitatively differs in GlA+ and AG-EB+ erythroid cells. Hence, the erythroid cells express IFN-γ, TGF-β1, TNF-α and IL-10. The erythroid cells could be involved through the production of these cytokines in the regulation of such processes as self-renewal, proliferation and differentiation of cells of other blood-forming sites. .
Related content


By Narumi S. Yoneyama H. Inadera H. Nishioji K. Itoh Y. Okanoue T. Matsushima K.
Cytokine, Vol. 12, Iss. 7, 2000-07 ,pp. :




By Tsukaguchi K. de Lange B. Boom W.H.
Cellular Immunology, Vol. 194, Iss. 1, 1999-05 ,pp. :

